BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1973944)

  • 41. Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder.
    Bejerot S; Bodlund O
    Acta Psychiatr Scand; 1998 Nov; 98(5):423-4. PubMed ID: 9845182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hallucinogens, serotonin and obsessive-compulsive disorder.
    Delgado PL; Moreno FA
    J Psychoactive Drugs; 1998; 30(4):359-66. PubMed ID: 9924841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug treatment of obsessive-compulsive disorder.
    Zohar J; Insel TR
    J Affect Disord; 1987; 13(2):193-202. PubMed ID: 2960711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Markovitz PJ; Stagno SJ; Calabrese JR
    Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New pharmacologic approaches to obsessive compulsive disorder.
    Insel TR
    J Clin Psychiatry; 1990 Oct; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Animal behavior case of the month. Congo African Grey parrot examined because of feather picking and self-injurious behavior.
    Juarbe-Díaz SV
    J Am Vet Med Assoc; 2000 May; 216(10):1562-4. PubMed ID: 10825940
    [No Abstract]   [Full Text] [Related]  

  • 48. Clomipramine: a tricyclic antidepressant effective in obsessive compulsive disorder.
    Kelly MW; Myers CW
    DICP; 1990; 24(7-8):739-44. PubMed ID: 2197816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective serotonin reuptake inhibitors in OCD.
    Montgomery SA; Bullock T; Fineberg N; Montgomery D
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():255A-256A. PubMed ID: 1498831
    [No Abstract]   [Full Text] [Related]  

  • 50. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C; Murphy DL; Zohar J; Hill JL; Grover G; Insel TR
    Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder.
    Pizarro M; Fontenelle LF; Paravidino DC; Yücel M; Miguel EC; de Menezes GB
    Expert Opin Pharmacother; 2014 Jul; 15(10):1391-401. PubMed ID: 24766145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The treatment of the resistant obsessive-compulsive disorder: an update].
    Crespo Facorro B; Gomez-Hernández R
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(1):61-9. PubMed ID: 9133159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current concepts in the pharmacological treatment of obsessive-compulsive disorder.
    Zohar J; Zohar-Kadouch RC; Kindler S
    Drugs; 1992 Feb; 43(2):210-8. PubMed ID: 1372219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The psychopharmacological treatment of obsessive-compulsive disorder: a review.
    Insel TR; Murphy DL
    J Clin Psychopharmacol; 1981 Sep; 1(5):304-11. PubMed ID: 6174553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obsessive-compulsive disorder in elderly patients.
    Jackson CW
    Drugs Aging; 1995 Dec; 7(6):438-48. PubMed ID: 8601051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An open trial of buspirone in obsessive-compulsive disorder.
    Jenike MA; Baer L
    Am J Psychiatry; 1988 Oct; 145(10):1285-6. PubMed ID: 3048120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Drug treatment of compulsive disorder].
    Rapoport JL
    Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment for late-onset obsessive-compulsive disorder with parkinsonism.
    Agarwal A; Biswas D; Sadhu R
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):331-6. PubMed ID: 18806237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment-response by age at onset in obsessive-compulsive disorder.
    Fontenelle LF; do Rosário-Campos MC; Mendlowicz MV; Ferrão YA; Versiani M; Miguel EC
    J Affect Disord; 2004 Dec; 83(2-3):283-4. PubMed ID: 15555726
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacotherapy of obsessive compulsive disorder--experience with fluoxetine.
    Wood A; Tollefson GD; Birkett M
    Int Clin Psychopharmacol; 1993; 8(4):301-6. PubMed ID: 8277151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.